New portal online about clinical trials worldwide.

A new portal (www.ifpma.org/clinicaltrials), established by the International Federation of Pharmaceutical Manufacturers and Associations, links available online information about clinical trials worldwide.

Comments

Post a Comment

Popular posts from this blog

Amsterdam to Host EU Drug Agency

BRUSSELS (Reuters) - Amsterdam won the right to host the EU's EMA drug agency when it leaves London after Brexit after the Dutch city tied with Milan in a vote on Monday that was then decided by the drawing of lots, diplomatic sources said.

 The Council of the European Union confirmed the choice of Amsterdam to host the European Medicines Agency (EMA) but gave no official account of the three rounds of vote which ended with disappointment for the Italian favourite in a lucky dip. The outcome was welcomed by European pharmaceuticals bodies.
 The EMA had warned that many of its staff might quit, possibly disrupting healthcare in Europe, if governments had chosen a less attractive host city, notably in the ex-communist east. Eastern governments were left empty-handed when a first round of voting among eight candidates to host the European Banking Authority (EBA) snubbed Warsaw and Prague. Paris, Frankfurt and Dublin went through to the second round, diplomats said, with Paris only sl…
Read more

Early Intervention in Unstable CAD

For patients with non-ST elevation acute coronary syndromes, an early interventional strategy provides greater improvements in health-related quality of life (HRQOL) compared with a more conservative medical approach, new findings suggest.
The gains in HRQOL with angiography and revascularization, if indicated, appear to be largely due to improvements in angina grade, principal investigator Dr. Joseph Kim, from the London School of Hygiene & Tropical Medicine, told Reuters Health.
"And although these gains were small, they occurred without an increased risk of death or MI to patients," he emphasized.
The findings, from the third Randomized Intervention Trial of unstable Angina (RITA-3), are published in the January 18th Journal of the American College of Cardiology.
In the trial, 1810 patients with chest pain at rest and confirmed coronary artery disease were randomized to an early intervention strategy (i.e., maximal medical therapy plus early coronary arteriography with po…
Read more

Inflammatory Bowel Disease an Independent Risk Factor for MI

Image
Patients with inflammatory bowel disease (IBD) are at significantly higher risk for myocardial infarction (MI), particularly younger patients and women, compared with the general population, new research suggests.

The study emphasizes the need for closer monitoring and aggressive attention to cardiovascular risk factors, say the researchers.

"Patients with IBD who present with any cardiovascular complaints, including chest pain or shortness of breath, should be thoroughly evaluated by their physicians for a potential heart condition," lead investigators, Muhammad Panhwar, MD, and Mahazarin Ginwalla, MD, Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Ohio, advised in an email to theheart.org | Medscape Cardiology.

"Our hope is that this study prompts clinicians who care for IBD patients to start thinking about IBD as an additional risk factor for heart disease and to also screen them and treat their risk factors aggressively,&q…
Read more